Please login to the form below

Not currently logged in

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Research

UK clears NHS use of Gilead’s remdesivir for COVID-19 patients

GileadMHRA approved the drug under the Early Access to Medicines Scheme

From: Research

Merck buys Themis as part of drive for COVID-19 drugs and vaccines

Merck & Co HQDeal also adds a pipeline of vaccines for other infectious diseases as well as cancer

From: Regulatory

FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC

BMS buildingFinally wins approval in market dominated by rival Keytruda

From: Research

New data backs remdesivir for COVID-19, but rings hydroxychloroquine alarm bell

GileadRemdesivir could speed recovery of patients with COVID-19, but hydroxychloroquine may not be safe


Pharmaceutical Market Europe - May 2020

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Iona Everson

Have your say...

FDA gives Roche’s Tecentriq green light for first-line NSCLC

Company enters lucrative and competitive market dominated by Merck/MSD’s rival Keytruda

Roche Basel Switzerland

'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

Taking the ‘free’ out of ‘freelance’ and bringing it in-house

Let's face it, the freelance life offers numerous benefits

Stephanie Wasek

COVID-19 Updates and Daily News

Featured jobs


Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

WHITE PAPER 05: Improving the effectiveness of clinical trial recruitment materials
With exclusive research conducted by COUCH Health, gain insight into clinical trial recruitment materials best practice....
COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic...
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...